| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 78 |
| 1 | METFORMIN | 63 |
| 2 | METFORMIN ER 500 MG | 63 |
| 3 | METFORMIN ER 750 MG | 63 |
| 4 | NIVOLUMAB | 52 |
| 5 | PREDNISONE | 45 |
| 6 | LIRAGLUTIDE | 44 |
| 7 | OMEPRAZOLE MAGNESIUM | 43 |
| 8 | ASPIRIN | 42 |
| 9 | ADALIMUMAB | 40 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GIVOSIRAN SODIUM | 7 | 0.0045 |
| 1 | ELUXADOLINE | 13 | 0.0044 |
| 2 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 4 | 0.0044 |
| 3 | RILUZOLE | 6 | 0.0027 |
| 4 | TREMELIMUMAB | 11 | 0.0025 |
| 5 | SITAGLIPTIN PHOSPHATE | 5 | 0.0018 |
| 6 | BRIGATINIB | 6 | 0.0016 |
| 7 | SORAFENIB | 33 | 0.0016 |
| 8 | PONATINIB HYDROCHLORIDE | 8 | 0.0015 |
| 9 | BISMUTH SUBSALICYLATE | 8 | 0.0014 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 1 | mu-Opioid Receptor Agonist [EPC] | 13 | 0.0044 |
| 2 | Complement Factor D Inhibitor [EPC] | 1 | 0.0032 |
| 3 | Benzothiazole [EPC] | 6 | 0.0027 |
| 4 | Bismuth [EPC] | 8 | 0.0014 |
| 5 | GLP-2 Analog [EPC] | 15 | 0.0011 |
| 6 | Tetracycline-class Antibacterial [EPC] | 8 | 0.0010 |
| 7 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 8 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 36 | 0.0007 |